This menu provides the list of EV miRNAs identified by high-throughput analyses.
Refresh all contents
Search:
Dataset accession
miRBase accession
Mature name
Orthologous group
Superdomain:
All
Prokaryote
Eukaryote
Filter datasets:
- "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
- "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
By species
Bos taurus
Homo sapiens
In vitro/In vivo
Ex vivo
In vitro
In vivo
By sample type
Bone marrow CD34+ cells
Drug-resistant acute lymphoblastic leukemia cell (CCRF-CEM MDR variant VLB100)
Drug-resistant breast adenocarcinoma cell (MCF-7 MDR variant MCF-7/DX)
Gastric cancer cells (SGC-7901)
Liver cancer cells (CSQT-2)
Liver cancer cells (HCC-LM3)
Liver cancer cells (HepG2)
Liver cancer cells (MHCC-97L)
Lung cancer cells (A549)
Plasma
Saliva
Seminal plasma
Serum
By sample status
Acute myeloid leukemia
Cisplatin-resistant
Extremely severe hand, foot, and mouth disease
Grazing
Mild hand, foot, and mouth disease
Normal
Normal_Exiqon
Omeprazole-treated
Oral lichen planus patient
Transplant islets into mouse xenotransplantation-rejected
Vasectomy
Vasovasostomy
Maximum false positive rate (FPR):
Maximum true positive rate (TPR):
- FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
- TPR is the percentile of miRNA among the present miRNAs.
Please see user manual in the contact us/help menu for detail.
Number of molecules in one page:
100
200
All
The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.
Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.
Mature name
miRBase accession
FPR
TPR
Publication
Orthologous group
Identification count
All / Prokaryote / Eukaryote
(FPR<0.05,TPR<0.5)
hsa-miR-197-5p
MIMAT0022691
0.0e+0
1.0e-1
MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.
MIPF0000123_1
21
/
0
/
21
hsa-miR-197-5p
MIMAT0022691
2.3e-2
5.0e-1
Combined Evaluation of a Panel of Protein and miRNA Serum Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity.
Int J Cancer. 2014 Nov 12. doi: 10.1002/ijc.29324.
MIPF0000123_1
21
/
0
/
21
hsa-miR-197-5p
MIMAT0022691
0.0e+0
2.2e-5
Diagnostic profiling of salivary exosomal microRNAs in oral lichen planus patients.
Oral Dis. 2015 Sep 21. doi: 10.1111/odi.12374.
MIPF0000123_1
21
/
0
/
21
hsa-miR-197-5p
MIMAT0022691
0.0e+0
2.4e-7
Diagnostic profiling of salivary exosomal microRNAs in oral lichen planus patients.
Oral Dis. 2015 Sep 21. doi: 10.1111/odi.12374.
MIPF0000123_1
21
/
0
/
21
hsa-miR-197-5p
MIMAT0022691
1.5e-3
4.9e-1
Extracellular vesicle miR-7977 is involved in hematopoietic dysfunction of mesenchymal stromal cells via poly(rC) binding protein 1 reduction in myeloid neoplasms.
Haematologica. 2016 Jan 22. pii: haematol.2015.134932.
MIPF0000123_1
21
/
0
/
21
bta-miR-197
MIMAT0009257
0.0e+0
1.4e-1
Differences in Circulating microRNAs between Grazing and Grain-Fed Wagyu Cattle Are Associated with Altered Expression of Intramuscular microRNA, the Potential Target PTEN, and Lipogenic Genes.
PLoS One. 2016 Sep 9;11(9):e0162496. doi: 10.1371/journal.pone.0162496. eCollection 2016.
MIPF0000123_1
21
/
0
/
21
mne-miR-197
MIMAT0002602
1.4e-15
1.4e-15
Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.
MIPF0000123_1
21
/
0
/
21
hsa-miR-197-5p
MIMAT0022691
0.0e+0
1.9e-1
Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.
MIPF0000123_1
21
/
0
/
21
hsa-miR-197-5p
MIMAT0022691
0.0e+0
1.6e-1
Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.
MIPF0000123_1
21
/
0
/
21
hsa-miR-197-5p
MIMAT0022691
0.0e+0
1.1e-1
Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.
MIPF0000123_1
21
/
0
/
21
hsa-miR-197-5p
MIMAT0022691
0.0e+0
1.2e-1
Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.
MIPF0000123_1
21
/
0
/
21
hsa-miR-197-5p
MIMAT0022691
0.0e+0
3.2e-1
Tumor microenvironment interruption: a novel anti-cancer mechanism of Proton-pump inhibitor in gastric cancer by suppressing the release of microRNA-carrying exosomes.
Am J Cancer Res. 2017 Sep 1;7(9):1913-1925. eCollection 2017.
MIPF0000123_1
21
/
0
/
21
hsa-miR-197-5p
MIMAT0022691
0.0e+0
3.4e-1
Tumor microenvironment interruption: a novel anti-cancer mechanism of Proton-pump inhibitor in gastric cancer by suppressing the release of microRNA-carrying exosomes.
Am J Cancer Res. 2017 Sep 1;7(9):1913-1925. eCollection 2017.
MIPF0000123_1
21
/
0
/
21
hsa-miR-197-5p
MIMAT0022691
0.0e+0
2.3e-1
Tumor microenvironment interruption: a novel anti-cancer mechanism of Proton-pump inhibitor in gastric cancer by suppressing the release of microRNA-carrying exosomes.
Am J Cancer Res. 2017 Sep 1;7(9):1913-1925. eCollection 2017.
MIPF0000123_1
21
/
0
/
21
hsa-miR-197-5p
MIMAT0022691
0.0e+0
2.6e-1
Tumor microenvironment interruption: a novel anti-cancer mechanism of Proton-pump inhibitor in gastric cancer by suppressing the release of microRNA-carrying exosomes.
Am J Cancer Res. 2017 Sep 1;7(9):1913-1925. eCollection 2017.
MIPF0000123_1
21
/
0
/
21
hsa-miR-197-5p
MIMAT0022691
0.0e+0
1.3e-4
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000123_1
21
/
0
/
21
hsa-miR-197-5p
MIMAT0022691
0.0e+0
2.2e-2
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000123_1
21
/
0
/
21
hsa-miR-197-5p
MIMAT0022691
1.3e-3
1.3e-3
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000123_1
21
/
0
/
21
hsa-miR-197-5p
MIMAT0022691
8.6e-4
8.6e-4
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000123_1
21
/
0
/
21
<
[2]